Prognostic significance of serum p53 protein and p53 antibody in patients with surgical treatment for head and neck squamous cell carcinoma

Head and Neck

Volumn 23, Issue 4, 2001, Pages 286-291

  Chow, Vivian ^a   Yuen, Anthony Po Wing ^a,b   Lam, King Yin ^a   Ho, Wai Kuen ^a   Wei, William Ignace ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer; ELISA; Immunohistochemistry; Metastasis

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; PROTEIN P53;

ARTICLE; CANCER SURGERY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035088510     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.1032     Document Type: Article

References (25)

1. p53 Function and dysfunction
2. p53 mutation in human cancers
3. High incidence of p53 alterations (mutation, deletion, over-expression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions
4. Frequent p53 mutations in head and neck cancer
5. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of larynx
6. P53 tumor suppressor oncogene expression in squamous cell carcinoma of hypopharynx
7. Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous cell carcinoma of the tongue
8. Levels of p53 antigen in the plasma of patients with adenomas and carcinomas of the colon
9. Detection of serum p53 protein in lung cancer patients
10. Clinical significance of serum p53 antigen in patients with pancreatic carcinoma
11. The humoral response to oncoprotein p53 in head and neck cancer
12. Comparison between p53 staining in tissue sections and p53 proteins level measured by an ELISA technique
13. Analysis of the Anti-p53 response in cancer patients
14. Anti-p53 anti-bodies in sera of workers occupationally exposed to vinyl chloride
15. Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma
16. Implications of p53 alternations and anti-p53 antibody response in head and neck squamous cell carcinomas
17. Anti-p53 antibodies in serum of smokers and head and neck cancer patients
18. Head and neck cancer and p53 immunogenicity
19. p53 serum anti-bodies as prognostic indicator in head and neck cancer
20. Clinicopathological analysis of elective neck dissection for NO neck of early oral tongue carcinoma
21. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma
22. Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
23. Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma
24. Circulating p53 antibodies as early markers of oral cancer: Correlation with p53 alternations